There were no statistically significant differences in phospho-eIF2α expression between the normal diagnostic group and either the small cell lung carcinoma (SCLC) or mixed carcinoma (MC) diagnostic groups. The gene discussed is EIF2A; the disease is small cell lung carcinoma.